Phase II trial of intraperitoneal cisplatin combined with paclitaxel in patients with ovarian, fallopian tube and primary peritoneal carcinomas

被引:0
|
作者
Landrum, L.
Mannel, R.
McMeekin, D. [1 ]
Moore, K. [1 ]
Hyde, J.
Walker, J. [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
268
引用
收藏
页码:S105 / S105
页数:1
相关论文
共 50 条
  • [41] Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Sabbatini, Paul
    Dupont, Jakob
    Aghajanian, Carol
    Derosa, Felicia
    Poynor, Elizabeth
    Anderson, Sybil
    Hensley, Martee
    Livingston, Phillip
    Lasonos, Alexia
    Spriggs, David
    McGuire, William
    Reinartz, Silke
    Schneider, Sally
    Grande, Cathy
    Lele, Shashikant
    Rodabaugh, Kerry
    Kepner, James
    Ferrone, Soldano
    Odunsi, Kunle
    CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5503 - 5510
  • [42] Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: Results of a phase I/II trial
    Sabbatini, P
    Aghajanian, C
    Leitao, M
    Venkatraman, E
    Anderson, S
    Dupont, J
    Dizon, D
    O'Flaherty, C
    Bloss, J
    Chi, D
    Spriggs, D
    CLINICAL CANCER RESEARCH, 2004, 10 (09) : 2962 - 2967
  • [43] What Is the Benefit of Bevacizumab Combined with Chemotherapy in Patients with Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Malignancies?
    Cheng, X.
    Moroney, J. W.
    Levenback, C. F.
    Fu, S.
    Jaishuen, A.
    Kavanagh, J. J.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (05) : 566 - 572
  • [44] A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study
    Gould, Natalie
    Sill, Michael W.
    Mannel, Robert S.
    Thaker, Premal
    DiSilvestro, Paul A.
    Waggoner, Steven E.
    Yamada, S. Diane
    Armstrong, Deborah K.
    Fracasso, Paula M.
    Walker, Joan L.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (03) : 506 - 510
  • [45] A feasibility study of intravenous (IV) paclitaxel, intraperitoneal (IP) carboplatin, and IP paclitaxel in patients with epithelial ovarian carcinoma, fallopian tube carcinoma, or peritoneal carcinoma
    Nagao, S.
    Oishi, R.
    Iwasa, N.
    Shimizu, M.
    Hasegawa, K.
    Goto, T.
    Fujiwara, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Detection of NRG1 Fusion Events in Ovarian, Fallopian Tube, and Primary Peritoneal Carcinomas
    Evans, M.
    Tseng, J.
    Crymes, A.
    Reid, J.
    Oberley, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S123 - S123
  • [47] Safety and Outcome of Patients Treated with a Modified Outpatient Intraperitoneal Regimen for Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
    Battelli, Chiara
    Campo, Meghan
    Buss, Mary K.
    Awtrey, Christopher S.
    Konstantinopoulos, Panagiotis A.
    CHEMOTHERAPY, 2013, 59 (04) : 251 - 259
  • [48] A phase II trial of pembrolizumab in combinationwith bevacizumab and oral metronomic cyclophosphamide for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
    Zsiros, E.
    Frederick, P. J.
    Akers, S. N.
    Attwood, K.
    Wang, K.
    Lele, S. B.
    Odunsi, K.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 23 - 23
  • [49] Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial
    Cowan, Mathew
    Swetzig, Wendy M.
    Adorno-Cruz, Valery
    Pineda, Mario J.
    Neubauer, Nikki L.
    Berry, Emily
    Lurain, John R.
    Shahabi, Shohreh
    Taiym, Deanna
    Nelson, Valerie
    O'Shea, Kaitlyn Lucrezia
    Kocherginsky, Masha
    Matei, Daniela
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 57 - 63
  • [50] PHASE I/II STUDY OF CARBOPLATIN AND PRALATREXATE IN PATIENTS WITH RECURRENT PLATINUM SENSITIVE OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER
    del Carmen, M.
    Campos, S.
    Krasner, C.
    Berlin, S.
    Supko, J.
    Atkinson, T.
    Birrer, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 419 - 420